after taking semaglutide Woman shares journey of weight loss and gain using The Pros, Cons, and Considerations

Summary: Current evidence suggests GLP-1 receptor agonists are not associated with increased breast cancer risk, though decisions should be individualised with multidisciplinary input

They function as targeted biological messengers, instructing your body to turn on specific healing cascades, downregulate systemic inflammation, and accelerate tissue repair

This article explores real-world trends in GLP-1 treatment adherence, reviews why patients discontinue therapy, and outlines practical ways clinicians can support persistence and improve long-term outcomes

Routine blood tests can help detect any early signs of liver or kidney stress